4Wagenknecht LE, Mayer EJ, Rewers Met al. The Insulin Resistance Atherosclerosis Study (IRAS): objectives,design, and recruitment results. Ann Epidemiol. 1995;5:464～472.
5Mayer-DavisEJ, Costacou T, King I etad. Plasma and dietary vitamin E in relation to incidence of type 2 diabetes:The Insulin Resistance and Athercsclerosis Study (IRAS).Diabetes Care. 2002; 25 (12): 2172～2177.
6Wagenknecht LE, Langefeld CD, Scherzinger AL et al.Insulin Sensitivity, Insulin Secretion, and Abdominal Fat:The Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes. 2003; 52 (10): 2490～2496.
7Festa A, D'Agostino R Jr, Howard G et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study. Circulation2000; 102:42～47.
8Festa A, D'Agostino R, Howard G et al. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.Kidney Int 2000; 58: 1703～ 1710.
9FestaA, D'Agostino R Jr, Tracy RP et al. C-reactive protein is more stronly related to post - glucose load glucose than to fasting glucose in non - diabetic subjects; the Insulin Resistance Atherosclerosis Study. Diabet Med 2002;19:939～943.
10FestaA, D'Agostino R Jr, Tracy RP et al. Elevated levels of acute - phase proteins and plasminogen activator inhibitor- 1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002;51:1131～1137.
